FIA
DFTX

FNY Investment Advisers’s Definium Therapeutics DFTX Stock Holding History

FNY Investment Advisers’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-9,094
Closed -$107K – 1240
2025
Q3 		$107K Buy
+9,094
New +$84.8K 0.03% 373
2021
Q4 		– Sell
-267
Closed -$9K – 711
2021
Q3 		$9K Sell
267
-2,486
-90% -$107K ﹤0.01% 550
2021
Q2 		$142K Buy
+2,753
New +$145K 0.06% 232

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

FNY Investment Advisers's DFTX Position: Q4 2025 in Review

FNY Investment Advisers sold out of Definium Therapeutics (DFTX) in Q4 2025, closing a stake of 9,094 shares — an estimated $107K sold.

FNY Investment Advisers first reported a position in DFTX in Q2 2021 and held it in 3 quarters. The position peaked at $142K in Q2 2021. 208 funds tracked by Wall St. Rank hold DFTX as of Q4 2025.

  • FNY Investment Advisers reported no remaining Definium Therapeutics position as of Q4 2025 after selling out during the quarter.
  • FNY Investment Advisers sold 9,094 Definium Therapeutics shares in Q4 2025, an estimated $107K.
  • FNY Investment Advisers first reported a position in Definium Therapeutics in Q2 2021 and held it in 3 quarters.
  • FNY Investment Advisers's Definium Therapeutics position peaked at $142K in Q2 2021.
  • 208 funds tracked by Wall St. Rank held Definium Therapeutics as of Q4 2025.

Based on FNY Investment Advisers's 13F filing for Q4 2025, filed 16 Jan 2026.